Algernon Pharmaceuticalsinc (AGN.CN)
0.0900 unch (unch) 03/21/25 [CNSX]
0.0850 x 12,000 0.1000 x 10,000
Realtime by (Cboe BZX)
0.0850 x 12,000 0.1000 x 10,000
Realtime - - (-) -
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2019 | 08-2018 | 08-2017 | 08-2016 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 27 | 41 | 128 | 48 |
| Accounts receivable | 11 | -2 | 25 | -34 |
| Other Working Capital | 94 | 44 | -76 | 0 |
| Other Operating Activity | -1,914 | -699 | -1,298 | -1,421 |
| Operating Cash Flow | $-1,782 | $-617 | $-1,221 | $-1,408 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | 55 | 0 | -60 | -31 |
| Net Acquisitions | 101 | N/A | 0 | 1,543 |
| Purchase Sale Intangibles | -66 | N/A | 0 | -97 |
| Investing Cash Flow | $90 | $0 | $-60 | $1,415 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 494 | 0 | 1,079 | 0 |
| Other Financing Activity | 154 | 472 | 0 | 185 |
| Financing Cash Flow | $648 | $472 | $1,079 | $185 |
| Exchange Rate Effect | 1 | 3 | -3 | 6 |
| Beginning Cash Position | 1,251 | 1,393 | 1,598 | 1,400 |
| End Cash Position | 208 | 1,251 | 1,393 | 1,598 |
| Net Cash Flow | $-1,044 | $-145 | $-203 | $192 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,782 | -617 | -1,221 | -1,408 |
| Capital Expenditure | -66 | N/A | -87 | -128 |
| Free Cash Flow | -1,848 | -617 | -1,308 | -1,536 |